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Abstract
Cerebral venous sinus thrombosis is a rare but dangerous condition, occurring with an incidence
of 3-4 cases/million/year. Cerebral venous sinus thrombosis presents a diagnostic challenge due to
its varied presentation patterns. We report a case of a 42 year old Nepali man diagnosed with
cerebral venous sinus thrombosis after presenting with a week long history of continuous
headache. He improved rapidly following prompt anticoagulation. Despite thorough investigation
no discernable underlying cause could be found. Our report highlights the value of prompt
diagnosis of cerebral venous sinus thrombosis through neuroimaging and the importance of
immediate anticoagulation as part of patient management.
Introduction
Cerebral venous sinus thrombosis (CVST) is an uncom-
mon condition affecting 3-4 cases/million/year with a
mean age of 37 to 38, though any age may be affected
[1,2]. Women tend to be at an increased risk particularly
between the ages of 20 - 35, mainly due to the use of the
oral contraceptive pill and the post partum state [1,3]. Pre-
disposing risk factors can be identified in up to 80% of
patients [4]. The clinical presentation of CVST is varied
and can include headache, vomiting and seizures. This
variation creates a diagnostic challenge for clinicians.
In this article we report a patient who developed a supe-
rior sagittal sinus thrombosis with no discernable under-
lying cause. It is hoped that the presentation of this case
will draw attention to this rare and potentially devastating
disease; helping increase clinicians' awareness of the clin-
ical characteristics, methods of diagnosis and manage-
ment of CVST.
Case presentation
A 42-year old Nepali male was admitted to the National
Institute of Neurological and Allied Sciences, Kathmandu
complaining of a week-long history of a continuous head-
ache. The headache was global in nature, with no associ-
ated vomiting. The evening preceding admission, the
patient had also noted photophobia, speech disturbance
and weakness of his right upper limb. There was no his-
tory of trauma, no relevant past medical or drug history
and no family history of note. The patient did however
mention partaking in unaccustomed strenuous activity
earlier in the week. On examination, the patient's obser-
vations were stable with a GCS of 15/15. His pupils, fundi
and speech appeared normal and there was no evidence of
any focal neurological deficit or meningism. A computer-
ized tomography (CT) scan appeared normal and lumbar
puncture showed an opening pressure of 30 cm H2O with
normal constituents. D-dimer and fibrinogen degradation
product (FDP) were marginally raised; all other parame-
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venography (MRV) confirmed the presence of a superior
sagittal sinus thrombosis with a small venous infarct (Fig-
ure 1) and the patient was subsequently anticoagulated
with enoxaparin and warfarin. Further investigations
including echocardiography, carotid artery Doppler, coag-
ulation studies and antiphospholipid antibody titres were
all normal. A follow-up MRV was performed 8 days after
diagnosis which showed improved perfusion throughout
the superior sagittal sinus (Figure 2). The patient made a
good recovery and was subsequently discharged home 10
days post admission.
Discussion
Venous drainage of the brain involves blood flow through
cerebral veins into the dural sinuses that then drain into
the internal jugular vein. As in our reported case, the supe-
rior sagittal sinus is the main cerebral venous sinus
affected by thrombus and is involved in 62% of cases [5].
The underlying pathogenesis of CVST involves two mech-
anisms. The first includes localized oedema and venous
infarction due to cerebral vein occlusion. The second
mechanism constitutes the development of raised intrac-
ranial pressure due to occlusion of one of the cerebral
venous sinuses, since CSF absorbed by the arachnoid villi
drains into the superior sagittal sinus [5]. Our patient
demonstrated signs of both these mechanisms. However,
it has been shown that, in a fifth of cases, only raised
intracranial pressure occurs with no signs of cortical vein
thrombosis [6].
Predisposing risk factors are found in 80% [4]. This may
include prothrombotic conditions [4], head injury [7],
inflammatory disease [8], dehydration [9] and malig-
nancy [6,9]. After extensive investigation, our patient
demonstrated no underlying risk factors associated with
CVST. Given that the patient lives in Kathmandu which
lies 1324 m above sea level we can tentatively speculate
that this high altitude may have had a hand in the forma-
tion of the CVST as this has been demonstrated in a
number of previous cases [10,11]. It should be mentioned
however, that patient suffering from thrombophilic states
have been shown to be at particular risk of developing
CVST at high altitude [12,13]. Institutional experience
suggests that CVST can represent an aspect of high altitude
illness and should be included as a differential for patients
presenting with high altitude cerebral oedema [unpub-
lished]. Further to this, the patient describes unaccus-
tomed strenuous exercise prior to development of his
headache which may indicate that dehydration may have
also played a part in the development of his CVST.
The variation in which CVST presents makes it a diagnos-
tic challenge. Our reported patient presented with a pri-
mary complaint of continuous headache which occurs in
over 90% of cases [5]. Symptoms tend to develop insidi-
ously over days to weeks [2]. However, sudden onset with
a thunderclap headache has been reported [14]. Rarely, a
unilateral focal neurological lesion such as hemiparesis
may develop however this typically becomes bilateral in
MRV 2 days post admission demonstrating thrombosis of the superior saggital sinus (arrows)Figu e 1
MRV 2 days post admission demonstrating thrombo-
sis of the superior saggital sinus (arrows).
MRV 8 days post diagnosis showing improved perfusion of the superior sagittal sinus foll antic agulation (arrows)Figure 2
MRV 8 days post diagnosis showing improved per-
fusion of the superior sagittal sinus following antico-
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and act as a helpful differentiator between venous and
arterial thromboses [5]. Raised intracranial pressure can
lead to visual disturbances and papilloedema on fundos-
copy [15].
Investigations are used in this condition in confirming the
diagnosis, and establishing any predisposing causes. Ini-
tially, conventional CT scanning is usually performed to
exclude other possible diagnoses such as subarachnoid
haemorrhage. In 35% of published cases, CT scanning
with contrast enhancement may demonstrate an 'empty
delta sign' which is a useful radiological sign for the diag-
nosis of superior sagittal sinus thrombosis [16]. Further-
more, the use of transcranial color-coded duplex
sonography (TCCS) is becoming increasingly common as
a complement to other imaging techniques in the diagno-
sis of CVST [17]. Other initial investigations may include
lumbar puncture, which has been found to be abnormal
in 84% of cases of CVST, and may also be helpful in ruling
out other diagnoses. The CSF abnormalities noted in our
patient (raised opening pressure) are well-recognized in
CVST, along with increased protein content and pleocyto-
sis [18]. The preferred and most sensitive diagnostic inves-
tigation is magnetic resonance venography (MRV) [19]
which allows the venous occlusion to be identified along
with any consequences such as cerebral oedema and areas
of venous infarction, as was present in our patient's case.
It has been suggested that CT venography detects CVST
with equal accuracy and may be advantageous in allowing
a prompt diagnosis immediately after the initial CT scan
[20]. If doubt remains following MRV, invasive cerebral
angiography may be performed.
Initial management of patients with confirmed CVST
should include stabilization and the prevention of cere-
bral herniation. This may involve the use of Mannitol or
surgery [5]. Despite the risk of haemorrhage into venous
infarcts, anticoagulation forms the mainstay of treatment,
even in the presence of an existing haemorrhagic venous
infarct [21], thus heparin is usually given after confirma-
tion of the diagnosis. A prospective study found that 79%
of patients recovered with this treatment [6]. Our patient
showed marked clinical and radiological improvement
following administration. Warfarin is usually continued
for 6 months, or longer in the presence of predisposing
conditions, with a target INR above 2.5 in order to reduce
the risk of recurrent cerebral and extracranial thromboses.
In cases where prognosis appears poor, endovascular
thrombolysis, with agents such as urokinase and tissue
plasminogen activator, may be used [5]. Other treatment
options include the use of therapeutic lumbar punctures,
oral acetazolamide and surgery in treating intracranial
hypertension.
The prognosis of CVST is usually favourable but is worse
in extremes of age, those with underlying conditions such
as malignancy and sepsis, and in the presence of coma or
deep cortical venous thrombosis [4]. More than 80% of
patients, as in our case, have a good neurological outcome
[5].
Conclusion
CVST is a challenging condition due to its wide range of
clinical presentations. Clinicians should have a high index
of suspicion, even in the absence of predisposing condi-
tions, in order to facilitate a prompt diagnosis through
neuroimaging. Expedited standard management for the
CVST should be employed to help ensure the best possible
outcome for patients.
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